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Abstract We present a compartmental mathematical model with demography for
the spread of the COVID-19 disease, considering also asymptomatic infectious
individuals. We compute the basic reproductive ratio of the model and study the
local and global stability for it. We solve the model numerically based on the case
of Italy. We propose a vaccination model and we derive threshold conditions for
preventing infection spread in the case of imperfect vaccines.
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1 Introduction
In late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) [1], a strain of coronavirus that causes coronavirus disease 2019 (COVID-19),
appeared in Wuhan, China, and rapidly spread across the globe. In January 2020 the
human-to-human transmission of SARS-CoV-2 was confirmed, during the COVID-
19 pandemic, and SARS-CoV-2 was designated a Public Health Emergency of
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International Concern by the WHO, and in March 2020 the WHO declared it a
pandemic. Since December 31, 2019, and as of July 23, 2020, 15,455,848 cases of
COVID-19 (in accordance with the applied case definitions and testing strategies in
the affected countries) are confirmed in more than 227 countries and 26 cruise ships
[2]. Currently, there are 5,415,828 active cases and 631,775 deaths.
Italy is one of the countries suffering the most with the COVID-19 outbreak. One
of the most critical facts about COVID-19, that affected Italy too, is that a significant
number of cases, mainly those of young age, has been reported as asymptotic [3],
leading to fast spread of the infection. Fortunately, asymptomatic cases have a shorter
duration of viral shedding and lower viral load [4, 5]. However, the proportion
of asymptomatic cases can range from 4%-80% [6] and most of the time they
play a key role in infection transmission, therefore it is very important to model
both symptomatic and asymptomatic cases. The most crucial element of COVID-
19 pandemic is demography. After the end of the quarantine and lock-down there
have been many examples of countries where the number of cases increased rapidly.
Although, demography is a very important element in epidemics and especially in the
case of COVID-19, only a fewmodels describe the dynamics of infectionwith SARS-
CoV-2 considering demographic terms. To this end, here we develop an SEIAR
model, considering both symptomatic and asymptomatic cases, and demographic
terms, with a constant influx of susceptible individuals. In this studywe only consider
horizontal infection transmission1.
As the development of a vaccine against SARS-CoV-2 is an urgent demand2, a
study of the epidemiological consequences that an imperfect potential vaccine can
have is needed, and to the best of our knowledge, there is currently no relevant study
in the literature. Here, we develop a theoretical framework to assess the vaccine
effectiveness and the epidemiological consequences of a potential vaccine. Given
that the second phase might lead to more asymptotic cases than the first phase we
need to investigate the asymptotic group for different coverage and efficacy. The
model derived in this study provides new insights on the effect of different vaccine
coverage and efficacy on infection spread in a population with demographics.
This study is organized as follows. In Section 2, we develop a new SEIAR model
for COVID-19. We derive the R0 of the model and we study the local and global
stability of the steady states. Numerical result with a focus on data fitted to Italy case
are presented. In Section 3, we extend our model including also a vaccinated group
of individuals, we study the global stability of the steady states and we predict the
vaccine effectiveness. We conclude in Section 4 with a summary and discussion of
future directions.
1 Horizontal transmission is transmission by direct contact between infected and susceptible
individuals or between disease vectors and susceptible individuals, that are not in a parent-progeny
relationship. Vertical transmission is the passage of the disease-causing agent from mother to baby
during the period immediately before and after birth.
2 During the days of writing this paper, promising progress has been announced in this direction.
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2 Modelling Transmission Dynamics
2.1 An SEIAR model for COVID-19
In this Section we model the transmission of SARS-CoV-2 among people causing
COVID-19. To derive our model we consider people who have been in contact
with an infectious individual, but remain uninfected for a latency period. Moreover,
a significant number of individuals being infected remain asymptomatic, due to
various factors such as age, health condition etc [3]. To this end, we classify the
total population (N) into five subclasses: susceptible (S), latent (E), symptomatic
infectious (I), asymptomatic infectious (A), and recovered (R) individuals, hence we
have that S + E + I + A + R = N . We can consider that N is practically constant,
since the time-span of the epidemiological phenomenon is relatively short and N
is relatively large. We take into account demographic terms and we consider the
transmission to be exclusively horizontal. The SEIAR model is governed by the
following system of nonlinear ordinary differential equations:
dS
dt
= µN − βISI − βASA − µS, (1a)
dE
dt
= βISI + βASA − (k + µ) E, (1b)
dI
dt
= k (1 − q) E − (γI + µ) I, (1c)
dA
dt
= kqE − (γA + µ) A, (1d)
dR
dt
= γI I + γAA − µR, (1e)
with initial conditions:
(S (0) , E (0) , I (0) , A (0) , R (0)) = (S0, E0, I0, A0, R0) ∈
(
R+0
)5
, (2)
where µ is the birth/death rate, βI and βA the transmission rates of I and A, respec-
tively3, k the incubation rate, i.e. the rate of latent individuals becoming infectious,
q the proportion of asymptotic infectious individuals, γI and γA the recovery rates
of infectious and asymptotic infectious individuals, respectively. A flow diagram of
the model is illustrated in Fig. 1. A straightforward application of the classical ODE
theory yields that the above Cauchy problem is well-posed.
3 βI ,A ≡ c$I ,A
N
, where c is the average number of close contacts of an individual with other
individuals and $I ,A is the probability of a contact to be effective in turning an S individual into
an I or A one, respectively.
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Fig. 1: Flow diagram of the SEIAR model (1).
2.2 The Basic Reproductive Ratio
The average number of secondary cases arising from one infection when the entire
population is susceptible is defined as the basic reproductive ratio and denoted by
R0. Being the most important quantity on infectious disease epidemiology, the basic
reproductive ratio is a dimensionless quantity, which is often used to reflect how
infectious a disease is. To define R0 we calculate the next-generation matrix of the
system, see, e.g., [7, 8].
First, we linearise model (1) around the disease-free steady state, (N, 0, 0, 0, 0),
and we consider the infected states, i.e. E, I, A, to obtain the linearised infection
subsystem
dE
dt
= βINI + βANA − (k + µ) E, (3a)
dI
dt
= k (1 − q) E − (γI + µ) I, (3b)
dA
dt
= kqE − (γA + µ) A. (3c)
Then, we set x = (E, I, A)tr, so that the system (3a)-(3c) can be written in the form
dx
dt
= (T + Σ) x,
where
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T =

0 βIN βAN
0 0 0
0 0 0

is the transmission matrix, and
Σ =

− (k + µ) 0 0
k (1 − q) − (γI + µ) 0
kq 0 − (γA + µ)

is the transition matrix.
Then, R0 is defined as the dominant eigenvalue of matrix K = −TΣ−1 as follows:
K = −TΣ−1 = −

0 βIN βAN
0 0 0
0 0 0
 ·

− 1(k + µ) 0 0
− k (1 − q)(k + µ) (γI + µ) −
1
(γI + µ) 0
− kq(k + µ) (γA + µ) 0 −
1
(γA + µ)

=

βINk (1 − q)
(k + µ) (γI + µ) +
βANkq
(k + µ) (γA + µ)
βIN
(γI + µ)
βAN
(γA + µ)
0 0 0
0 0 0
 ,
from which we obtain that
R0 = βINk (1 − q)(k + µ) (γI + µ) +
βANkq
(k + µ) (γA + µ) . (4)
2.3 Local Stability Analysis of the SEIAR Model
We proceed with the local stability analysis of the model. The Jacobian matrix of
system (1) is
J =

−βI I − βAA − µ 0 −βIS −βAS 0
βI I + βAA − (k + µ) βIS βAS 0
0 k (1 − q) − (γI + µ) 0 0
0 kq 0 − (γA + µ) 0
0 0 γI γA −µ

. (5)
Theorem 1 If R0 < 1, the disease-free steady state, (N, 0, 0, 0, 0), of system (1) is
locally stable.
Proof For the disease-free steady state (N, 0, 0, 0, 0) we obtain a double negative
eigenvalue, λ1 = −µ, and the characteristic equation of the reduced 3x3 matrix
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λ3+
(
γI + γA + k + 3µ
)
λ2 +
[
(k + µ) (γI + γA + 2µ) + (γI + µ) (γA + µ)
− Nk (βI (1 − q) + βAq)
]
λ + (k + µ) (γI + µ) (γA + µ)
− Nk
(
βI (1 − q) (γA + µ) + βAq (γI + µ)
)
= 0.
We prove the stability of this steady state using the Routh-Hurwitz criterion [9].
The disease-free steady state is stable if and only if
γI + γA + k + 3µ > 0, (6)
(k + µ) (γI + µ) (γA + µ) − βINk (1 − q) (γA + µ) − βANkq (γI + µ) > 0, (7)
(γI + γA + k + 3µ)
[
(k + µ) (γI + γA + 2µ) + (γI + µ) (γA + µ)
− Nk
(
βI (1 − q) + βAq
)]
− (k + µ) (γI + µ) (γA + µ)
+ Nk
(
βI (1 − q) (γA + µ) + βAq (γI + µ)
)
> 0. (8)
The inequality (6) holds always. The inequality (7) can be equivalently written as
R0 = βINk (1 − q)(k + µ) (γI + µ) +
βANkq
(k + µ) (γA + µ) < 1. (9)
By using Mathematica [10] we can confirm that the inequality (8) holds for R0 < 1,
thus the disease-free steady state is stable. 
Theorem 2 If R0 > 1, the endemic steady state, (S∗, E∗, I∗, A∗, R∗), of system (1)
with
S∗ =
(γI + µ) (γA + µ) (k + µ)
k (βI (γA + µ) + q (βA (γI + µ) − βI (γA + µ))) =
N
R0 ,
E∗ =
Nµ
(k + µ)
(
1 − 1R0
)
,
I∗ =
Nk (1 − q) µ
(γI + µ) (k + µ)
(
1 − 1R0
)
,
A∗ =
Nkqµ
(γA + µ) (k + µ)
(
1 − 1R0
)
,
R∗ =
Nk
(
qγAµ + γI (γA + µ − qµ)
)
(γI + µ) (γA + µ) (k + µ)
(
1 − 1R0
)
,
(10)
is locally stable.
Proof The characteristic equation of the Jacobian matrix (5) at the endemic steady
state is
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λ4 + α3λ
3 + α2λ
2 + α1λ + α0 = 0,
with
α3 =γI + γA + k + 3µ + µR0 > 0,
α2 =µR0 (γI + γA + k + 3µ) + (γI + γA + 2µ) (k + µ) + (γI + µ) (γA + µ)
− NR0 k (βI (1 − q) + βAq) ,
α1 =µR0 (γI + γA + 2µ) (k + µ) + (γI + µ) (γA + µ) (µR0 + k + µ)
− NR0 k (βI (1 − q) (γA + µ + 1) + βAq (γI + µ + 1)) ,
α0 =µR0 (k + µ) (γI + µ) (γA + µ) − µ NR0 k (βI (1 − q) (γA + µ) + βAq (γI + µ)) .
From the Routh-Hurwitz criterion, the endemic steady (10) is locally stable if and
only if
α0 > 0, α1 > 0, α3 > 0 and α1α2α3 − α21 − α0α23 > 0.
We have that α3 > 0 always, whereas a0 > 0 is equivalent to R0 > 1. By using
Mathematica [10] we can confirm that the rest of the above relations hold for R0 > 1,
thus the endemic steady state is stable. 
2.4 Global Stability Analysis of the SEIAR Model
Theorem 3 If R0 ≤ 1, then the disease-free steady state, (N, 0, 0, 0, 0), of system (1)
is globally asymptotic stable.
Proof We prove the global stability of the disease-free steady state (N, 0, 0, 0, 0) by
constructing a Lyapunov function. We consider the functionV1 : (R+)4 → R+ with
V1 (S (t) , E (t) , I (t) , A (t)) =
(
S − N − N ln S
N
)
+ E +
NβI
γI + µ
I +
NβA
γA + µ
A.
We take the derivative ofV1 with respect to t:
V ′1 = S′
(
1 − N
S
)
+ E ′ +
NβI
γI + µ
I ′ +
NβA
γA + µ
A′
= 2µN − µS − µN
2
S
+ E (k + µ)
(
βINk (1 − q)
(k + µ) (γI + µ) +
βANkq
(k + µ) (γA + µ) − 1
)
= −µN
(
S
N
+
N
S
− 2
)
+ E (k + µ) (R0 − 1) .
Thus, if R0 ≤ 1 then V ′1 ≤ 0 for all t ≥ 0 and (S, E, I, A) ∈ (R+)4 sufficiently
close to (N, 0, 0, 0), and V ′1 (t) = 0 holds only for (S, E, I, A) = (N, 0, 0, 0). Hence,
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the singleton {(N, 0, 0, 0)} is the largest invariant set for which V ′1 = 0. Then,
from LaSalle’s Invariant Principle [11] it follows that the disease-free steady state is
globally asymptotic stable. 
Theorem 4 If R0 > 1, then the endemic steady state, (S∗, E∗, I∗, A∗, R∗), of system
(1) is globally asymptotic stable.
Proof We consider the functionV2 : (R+)4 → R+ with
V2 (S (t) , E (t) , I (t) , A (t)) =
(
S − S∗ − S∗ ln S
S∗
)
+
(
E − E∗ − E∗ ln E
E∗
)
+
βIS∗
γI + µ
(
I − I∗ − I∗ ln I
I∗
)
+
βAS∗
γA + µ
(
A − A∗ − A∗ ln A
A∗
)
.
We take the derivative ofV2 with respect to t:
V ′2 =S′
(
1 − S
∗
S
)
+ E ′
(
1 − E
∗
E
)
+
βIS∗
γI + µ
I ′
(
1 − I
∗
I
)
+
βAS∗
γA + µ
A′
(
1 − A
∗
A
)
= (µN − βISI − βASA − µS)
(
1 − S
∗
S
)
+ (βISI + βASA − (k + µ) E)
(
1 − E
∗
E
)
+
βIS∗
γI + µ
(k (1 − q) E − (γI + µ) I)
(
1 − I
∗
I
)
+
βAS∗
γA + µ
(kqE − (γA + µ) A)
(
1 − A
∗
A
)
.
After using the relations
µN = βIS∗I∗ + βAS∗A∗ + µS∗,
and
βIS∗I∗ + βAS∗A∗ = (k + µ) E∗, k (1 − q) E∗ = (γI + µ) I∗, kqE∗ = (γA + µ) A∗,
and adding and subtracting the terms
βIS∗I∗
2
E
IE∗
and
βAS∗A∗
2
E
AE∗
we have
V ′2 = − µS∗
(
S
S∗
+
S∗
S
− 2
)
− βIS∗I∗
(
S∗
S
+
S
S∗
I
I∗
E∗
E
+
I∗
I
E
E∗
− 3
)
− βAS∗A∗
(
S∗
S
+
S
S∗
A
A∗
E∗
E
+
A∗
A
E
E∗
− 3
)
.
From the arithmeticâĂŞgeometric mean inequality we have that
1
3
(
S∗
S
+
S
S∗
I
I∗
E∗
E
+
I∗
I
E
E∗
)
≥ 3
√
S∗
S
S
S∗
I
I∗
E∗
E
I∗
I
E
E∗
= 1,
and
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1
3
(
S∗
S
+
S
S∗
A
A∗
E∗
E
+
A∗
A
E
E∗
)
≥ 3
√
S∗
S
S
S∗
A
A∗
E∗
E
A∗
A
E
E∗
= 1,
henceV ′2 ≤ 0 for all (S, E, I, A) ∈ (R+)4, and the equality holds only for the endemic
steady state (S∗, E∗, I∗, A∗). We conclude again from LaSalle’s Invariance Principle
that the endemic steady state is globally asymptotic stable.
2.5 Numerical simulations for the SEIAR model
We proceed to the estimation of the already known epidemic curve of the disease in
Italy, as obtained from the data set [12], by
dR
dt
(see, e.g., [13] and [14]). We plot
together the two functions in Fig. 2. The total population of Italy is 60,456,999. Once
the restriction of movement (quarantine) during the manifestation of COVID-19 was
applied, it limited the spread of the disease. To this end we follow the approach in
[15] and we consider as the total population of N = 60,456,999/250.
Fig. 2: Number of confirmed cases per day in Italy. The blue dots represents the
data obtained from [12] and the red curve the graph of
dR
dt
, as obtained by (1). The
parameters used here are: βI = 2.55/N, βA = 1.275/N, k = 0.07, µ = 0.001, γI =
0.0625, γA = 0.083, q = 0.425, and initial conditions (ICs): S0 = N − 200, I0 =
100, A0 = 100, E0 = R0 = 0.
In Fig. 3 we show the dynamics of the proportion of the values of model (1) for
the set of parameters used in Fig. 2. We see in Fig. 3a that for this set of parameters
the solution of the system has an oscillatory behaviour towards the endemic steady
state. This can be more clear in Fig. 3b, where the proportion of the infectious
population (both symptomatic and asymptomatic) oscillates towards the proportion
of the steady state I∗ + A∗.
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(a) (b)
Fig. 3: The dynamics of the proportion of the values of model (1). (a) For all
subgroups; (b) For the groups of both symptomatic and asymptomatic infectious
individuals, I + A, towards the steady state I∗ + A∗. The parameters used are the
same as in Fig. 2 (see also Table 1). The initial conditions are: S0 = 1− 0.0008, I0 =
0.0004, A0 = 0.0004, E0 = R0 = 0.
3 Modelling transmission dynamics of COVID-19 in a vaccinated
population
In this section we consider the subclass of the vaccinated-with-a-prophylactic-
vaccine (V) individuals. We set 0 ≤ p ≤ 1 for the vaccine coverage, as well as
0 ≤  < 1 for the vaccine efficacy [16]. Then, the model becomes
dS
dt
= (1 − p) µN − βISI − βASA − µS, (11a)
dV
dt
= pµN − (1 − ) (βIVI + βAVA) − µV, (11b)
dE
dt
= (S + (1 − )V) (βI I + βAA) − (k + µ) E, (11c)
dI
dt
= k (1 − q) E − (γI + µ) I, (11d)
dA
dt
= kqE − (γA + µ) A, (11e)
dR
dt
= γI I + γAA − µR, (11f)
along with the initial condition:
(S (0) ,V (0) , E (0) , I (0) , A (0) , R (0)) = (S0,V0, E0, I0, A0, R0) ∈
(
R+0
)6
. (12)
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Following the same steps as before and using the disease-free steady state of the
model, ((1 − p) N, pN, 0, 0, 0, 0), we have that the basic reproductive ratio for the
model where vaccination is applied is
RV0 = (1 − p)
(
βINk (1 − q)
(k + µ) (γI + µ) +
βANkq
(k + µ) (γA + µ)
)
= (1 − p) R0. (13)
The endemic steady state, (S∗,V∗, E∗, I∗, A∗, R∗), of model (11) is
( (1 − p) N
RV0
,
pN
RV0
,
Nµ
(k + µ)
(
1 − 1RV0
)
,
(1 − p) Nk (1 − q) µ
(γI + µ) (k + µ)
(
1 − 1RV0
)
,
(1 − p) Nkqµ
(γA + µ) (k + µ)
(
1 − 1RV0
)
,
(1 − p) Nk
(
qγAµ + γI (γA + µ − qµ)
)
(γI + µ) (γA + µ) (k + µ)
(
1 − 1RV0
))
.
Fig. 4: Flow diagram of the SVEIAR model (11).
We prove the global stability of the model following the same steps as before.
Theorem 5 If RV0 ≤ 1, then the disease-free steady state, ((1 − p) N, pN, 0, 0, 0, 0),
of system (11) is globally asymptotic stable.
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Proof We prove that the disease-free steady state of system (11) is globally asymp-
totic stable by applying again the LaSalle’s Invariant Principle for the Lyapunov
functionVV1 : (R+)5 → R+ with
VV1 (S (t) ,V (t) , E (t) , I (t) , A (t)) =
(
S − (1 − p) N − (1 − p) N ln S(1 − p) N
)
+
(
V − pN − pN ln V
pN
)
+ E +
(1 − p) NβI
γI + µ
I +
(1 − p) NβA
γA + µ
A,
and following the steps corresponding to the proof of Theorem 3. 
Theorem 6 If RV0 > 1, then the endemic steady state, (S∗,V∗, E∗, I∗, A∗, R∗), of
system (11) is globally asymptotic stable.
Proof We prove that the endemic steady state of system (11) is globally asymptotic
stable by applying again LaSalle’s Invariant Principle for the Lyapunov function
VV2 : (R+)5 → R+, with
VV2 (S (t) ,V (t) , E (t) , I (t) , A (t)) =
(
S − S∗ − S∗ ln S
S∗
)
+
(
V − V∗ − V∗ ln V
V∗
)
+
(
E − E∗ − E∗ ln E
E∗
)
+
βIS∗ + (1 − ) βIV∗
γI + µ
(
I − I∗ − I∗ ln I
I∗
)
+
βAS∗ + (1 − ) βAV∗
γA + µ
(
A − A∗ − A∗ ln A
A∗
)
,
and following the steps corresponding to the proof of Theorem 4. 
3.1 Numerical simulations for the SVEIAR
To assess vaccine effectiveness we focus on three important epidemiological mea-
sures [17]: (i) the risk of infection spread, represented byRV0 ; (ii) the peak prevalence
of infection; (iii) the time at which the peak prevalence occurs. Relation (13) shows
that the vaccine coverage, p, and vaccine efficacy,  , act multiplicatively on R0. As
the proportion of asymptotic cases is still unknown, in Fig 5a we present a contour
plot of the dependence of RV0 on the vaccine coverage and vaccine efficacy, for dif-
ferent proportion of asymptotic cases. The coloured curves represent the threshold
RV0 = 1 in (13), between the infection spread (represented by the area below the
threshold; RV0 > 1) or not (represented by the area above the threshold; RV0 < 1).
The plot indicates that the vaccine efficacy and coverage need to be greater for small
proportion of asymptotic cases. As the number of asymptotic cases increases a more
effective vaccine is needed. We see that even for a severe COVID-19 epidemic, as
in our case, the vaccine can prevent the infection spread if both the vaccine efficacy
and the vaccine coverage are high. Considering however that the data reflect a period
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where the severity of COVID-19 was not yet known and the average number of
close contacts between individuals was very high due to occasions and events, the
transmission rate, βI , as obtained by the data is not the most appropriate index to
predict vaccine effectiveness, as the situation has changed dramatically and close
contacts have been significantly reduced. Hence, in Fig 5b we present a correspond-
ing contour plot for a lower βI . We see that in the case of a reduced transmission rate
the vaccine can prevent the infection spread, even for imperfect vaccines and small
vaccine coverage.
In Fig 6 we see the effect of vaccine efficacy on the proportion of the infection
dynamics for high (Fig 6a) and low (Fig 6b) transmission rates. Higher vaccine
efficacy leads to milder, but prolonged epidemics due to the slower rate of infection
transmission. Moreover, it causes later occurrence of the first infection incidence and
peak prevalence, and a slower rate of postpeak prevalence decline.
(a) (b)
Fig. 5: Assessing the vaccine effectiveness: A contour plot showing the dependence
of RV0 on the vaccine efficacy, vaccine coverage and proportion of asymptotic cases
for (a) βI = 2.55; (b) βI = 0.2. The rest of the model parameters are given in Table 1.
4 Conclusions
We presented an ad hoc SEIAR model with horizontal transmission and demo-
graphic terms for the epidemic spread of COVID-19, and we extended the model to
include vaccination. The stability of both models is proved by implementing suitable
Lyapunov functions; the model is fitted to real data from the epidemic in Italy. We
studied the condition under which a vaccine can prevent disease spread.We accessed
14 Vasiliki Bitsouni, Nikolaos Gialelis and Ioannis G. Stratis
(a) (b)
Fig. 6: Assessing the vaccine effectiveness: The effect of vaccination on the preva-
lence of infection, with ICs: S0 = V0 = 0.4996, I0 = A0 = 0.0004, and for (a)
βI = 2.55; (b) βI = 0.2. The rest of the model parameters are given in Table 1.
Table 1: Model parameters, values, units and relevant references.
Param. Description Value Unit Reference
µ Birth/Death rate 0.001(2 · 10−5 − 0.001) days−1 [18, 19]
βI Transmission rate of infectious individuals 2.55(0.14 − 2.55) individuals−1 ·days−1 [5, 15, 20, 21,
22]
βA Transmission rate of asymptotic infectious individ-
uals
βI
2
individuals−1 ·days−1 [5, 15, 20, 21, 22,
23]
k Incubation rate (rate of latent individuals becoming
infectious)
0.071(0, 071 − 0.2) days−1 [24, 25]
q Proportion of the asymptotic infectious individuals 0.425(0 − 1) - [3]
γI Recovery rate of the infectious individuals 0.0625(0.02 − 0.0625) days−1 [4, 26, 27]
γA Recovery rate of the asymptomatic infectious indi-
viduals
0.083(0.083 − 0.33) days−1 [4, 27]
p Proportion of vaccinated individuals 0.5(0 − 1) - Estimated
 Vaccine efficacy 0.5(0 − 1) - Estimated
the vaccine effectiveness focusing on the risk of infection spread, the peak prevalence
of infection and the time at which the peak prevalence occurs.
Future work includes further investigation of the vaccine model, by incorporating
different vaccination strategies, and if possible the comparison with biological data.
An extension of the model will also include additional important factors of COVID-
19 spread, such as the age and the waning immunity gained by infected individuals,
as well as vertical transmission and migration terms for the infected individuals.
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